EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”


Neil Docherty: University College Dublin - Ireland
Impaired branched chain amino acid metabolism: an effector of insulin resistance-associated kidney disease?

Jean-Francois Gautier: University Paris Cité - France
Blood monocyte frequency and phenotype as subclinical markers of cardiovascular risk in people with type 2 diabetes?

Patricia Iozzo: Institute of Clinical Physiology (IFC) - Pisa, Italy
PET (pharmaco)microbiomics imaging in relation to glucose control: proof-of-concept study

Marie Jeansson: Karolinska Institute - Huddinge, Sweden
A novel TIE2 activating treatment to alleviate diabetic complications in kidney, heart, and eye

Cedric Moro: Inserm UMR1297, Institute of Metabolic and Cardiovascular Diseases - Toulouse, France
Heart-brown adipose tissue crosstalk in type 2 diabetes development

Joergen Rungby: Steno Diabetes Centre Copenhagen - Denmark
Does peripheral nerve damage translate into cognitive failure in type 2 diabetes?

Milena Schönke: Leiden University Medical Center - Netherlands
Exercise in NAFLD: Exploring the muscle-gut-liver axis to identify new treatment targets

Kristina Schoonjans: Ecole Polytechnique Fédérale de Lausanne (EPFL) - Lausanne, Switzerland
Targeting obesity and diabetes through microbiome-tailored bile acid signalling

Julia Szendroedi: Heidelberg University Hospital  - Germany
Mechanisms and clinical implications of severe insulin resistant diabetes: the role of functional lipodystrophy

Thomas van Sloten: University Medical Center Utrecht - Netherlands
Microvasculature–brain interaction in type 2 diabetes: an ultrahigh field MRI study


Mijke Buitinga: University Maastricht - The Netherlands
Glycogen dynamics in prediabetes

Ulf Eriksson: Karolinska Institute - Stockholm, Sweden
Adipose-specific regulation of VEGF-B signalling in diabetic complications of liver, kidney and heart

Claire Hills: University of Lincoln - UK
The cardio-renal-metabolic role of NLRP3 and SASP in early SGLT2i therapy in diabetics with myocardial infarction

Joan-Marc Servitja: Clínic Foundation for Biomedical Research - Barcelona, Spain
Effects of circulating extracellular vesicles on pancreatic islets during obesity

Kfir Sharabi: The Hebrew University of Jerusalem - Israel
Deciphering the molecular mechanisms underlying gut-liver communication


Leen M. ‘t Hart: Leiden University Medical Center - Netherlands
Inter-organ communication via circulating small RNAs in diabetic CKD

Miriam Cnop: Université Libre de Bruxelles - Belgium
CCND2 gene variants protect from type 2 diabetes in obesity: an iPSC approach to study the adipose tissue-beta cell axis

Beatrice Maria Filippi: University of Leeds - UK
Identification of new molecular targets for insulin resistance in the brain

Nordin Hanssen: Amsterdam UMC - Netherlands
Does faecal microbiota transplantation preserve beta cell mass in type 1 diabetes?

Daniele Lettieri-Barbato: University of Rome Tor Vergata - Italy
Deciphering the role  of adipocyte to macrophage mitochondrial transfer in type 2 diabetes

Angela Martinez Valverde: Spanish National Research Council (CSIC) - Madrid, Spain
Extracelular vesicles: new insights into their role in liver-pancreas interactome in type 2 diabetes

Luciano Pirola: INSERM Unit 1060 - Lyon, France
Interaction between the liver and the kidney in governing ketone bodies metabolism

Jose Romero: University of Birmingham - UK
Rejuvenating mitochondria to alleviate premature senescence and multimorbidity in diabetes

Ana Teixeira: Karolinska Institute - Stockholm, Sweden
Mapping insulin receptor nanoclusters in metabolic tissues


Remy Burcelin: INSERM - Toulouse, France
Molecular control of insulin resistance by the host to microbiota crosstalk

Ulf Eriksson: Karolinska Institute - Stockholm, Sweden
VEGF-B signalling in diabetic complications of liver, kidney and heart

Shai Fuchs: The Sheba Fund for Health Services and Research - Ramat-Gan, Israel
Regulation of dysglycaemia and hepatosteatosis by the gut L-cell hepatic stellate cell axis

Sophie Lestavel: Université de Lille - France
Role of intestinal epithelial FXR in the Non Alcoholic Fatty Liver Disease complication of type 2 diabetes

Marcelina Parrizas: Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) - Barcelona, Spain
Experimental modulation of exosomal miRNA targets for the treatment of diabetes

Allan Vaag: Steno Diabetes Center Copenhagen - Gentofte, Denmark
Subcutaneous adipocyte pertubations and ectopic fat disposition in men with low birth weight

Rob Wust: Vrije University Amsterdam - Netherlands
NOX2 as the nexus between exercise intolerance and mitochondrial dysfunction in type 1 diabetes


Daniel Cuthbertson: University of Liverpool – United Kingdom
Metabolic and multi-organ effects of low-calorie diet in prediabetes and NAFLD

Ben Jones: Imperial College London – United Kingdom
Understanding the tissue-specific effects of biased GLP-1 receptor agonism in type 2 diabetes

Andreas F. H. Pfeiffer: Charité Universitaetsmedizin Berlin - Germany
FAIR - Fasting-Induced Immune-metabolic Remission of Diabetes

Romano Regazzi: University of Lausanne - Switzerland
Exosome-mediated RNA transfer between insulin target tissues and pancreatic beta cells

Jennifer Rieusset: INSERM U1060 - Lyon, France
Splanchnic triumvirate crosstalk through the dynamic regulation of MAMs by nutrients and GLP1

Maria Rohm: Helmholtz Center Munich - Neuherberg, Germany
A TBL1/TBLR1-dependent adipose tissue/beta cell axis controlling metabolism and glucose homeostasis